Pure Science Investments Limited
Unaudited Financial Statements
For the year ended 28 February 2023
For Filing with Registrar
Company Registration No. 10626952 (England and Wales)
Pure Science Investments Limited
Company Information
Directors
B. M. Kaufhold
J. C. W. Brown
Company number
10626952
Registered office
Charlotte Building
17 Gresse Street
London
W1T 1QL
Accountants
Moore Kingston Smith LLP
Charlotte Building
17 Gresse Street
London
W1T 1QL
Pure Science Investments Limited
Contents
Page
Balance sheet
1
Notes to the financial statements
2 - 4
Pure Science Investments Limited
Balance Sheet
As at 28 February 2023
Page 1
2023
2022
Notes
£
£
£
£
Fixed assets
Investments
3
101,000
101,000
Current assets
Debtors
4
1
1
Cash at bank and in hand
101
173
102
174
Creditors: amounts falling due within one year
5
(101,950)
(101,950)
Net current liabilities
(101,848)
(101,776)
Net liabilities
(848)
(776)
Capital and reserves
Called up share capital
6
1
1
Profit and loss reserves
(849)
(777)
Total equity
(848)
(776)
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The financial statements were approved by the board of directors and authorised for issue on 23 November 2023 and are signed on its behalf by:
B. M. Kaufhold
Director
Company Registration No. 10626952
Pure Science Investments Limited
Notes to the Financial Statements
For the year ended 28 February 2023
Page 2
1
Accounting policies
Company information
Pure Science Investments Limited is a private company limited by shares incorporated in England and Wales. The registered office is Kingston Smith, Charlotte Building, 17 Gresse Street, London, W1T 1QL.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Going concern
These financial statements are prepared on the going concern basis. The directors believe that the company will have sufficient funds to settle all of its liabilities as they fall due for at least 12 months from signing the accounts.
1.3
Fixed asset investments
Interests in subsidiaries, associates and jointly controlled entities are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
An associate is an entity, being neither a subsidiary nor a joint venture, in which the company holds a long-term interest and where the company has significant influence. The company considers that it has significant influence where it has the power to participate in the financial and operating decisions of the associate.
Entities in which the company has a long term interest and shares control under a contractual arrangement are classified as jointly controlled entities.
1.4
Cash at bank and in hand
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.5
Financial instruments
The company only has basic financial instruments measured at amortised cost, with no financial instruments classified as other or basic instruments measured at fair value.
1.6
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
Pure Science Investments Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2023
1
Accounting policies
(Continued)
Page 3
Changes in the fair value of derivatives that are designated and qualify as fair value hedges are recognised in profit or loss immediately, together with any changes in the fair value of the hedged asset or liability that are attributable to the hedged risk.
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2023
2022
Number
Number
Total
2
2
3
Fixed asset investments
2023
2022
£
£
Shares in group undertakings and participating interests
101,000
101,000
4
Debtors
2023
2022
Amounts falling due within one year:
£
£
Other debtors
1
1
5
Creditors: amounts falling due within one year
2023
2022
£
£
Amounts owed to group undertakings
101,450
101,450
Other creditors
500
500
101,950
101,950
Pure Science Investments Limited
Notes to the Financial Statements (Continued)
For the year ended 28 February 2023
Page 4
6
Called up share capital
2023
2022
£
£
Ordinary share capital
Issued and fully paid
10,000 ordinary shares of £0.0001 each
1
1
1
1
7
Parent company
The immediate and ultimate parent company is Pure Science Limited a company registered in England and Wales.